Murakami K, Ide T, Suzuki M, Mochizuki T, Kadowaki T
Central Research Laboratories, Kyorin Pharmaceutical Co., Ltd., Tochigi, Japan.
Biochem Biophys Res Commun. 1999 Jul 14;260(3):609-13. doi: 10.1006/bbrc.1999.0951.
The alpha isoform of peroxisome proliferators-activated receptor (PPAR) is activated by fatty acids, their metabolites, and the fibrate class of lipid-lowering agents. To test the ability of these activators to directly bind the ligand-binding domain of human PPARalpha, we performed a competitive binding assay using radiolabeled [(3)H]KRP-297, a known ligand for human PPARalpha. Long-chain fatty acids and eicosanoids were even more potent ligands for human PPARalpha than the hitherto most potent PPARalpha ligand WY-14,643. Moreover, these natural ligands avidly activated this receptor in a transient transcriptional assay. This study provides the direct evidence that human PPARalpha is activated through the direct binding of fatty acids and eicosanoids, as well as of a fibrate, to its ligand-binding domain.
过氧化物酶体增殖物激活受体(PPAR)的α亚型可被脂肪酸、其代谢产物以及贝特类降脂药物激活。为了测试这些激活剂直接结合人PPARα配体结合域的能力,我们使用放射性标记的[(3)H]KRP - 297(一种已知的人PPARα配体)进行了竞争性结合试验。长链脂肪酸和类花生酸是人PPARα比迄今最有效的PPARα配体WY - 14,643更有效的配体。此外,这些天然配体在瞬时转录试验中能有效激活该受体。本研究提供了直接证据,证明人PPARα是通过脂肪酸、类花生酸以及一种贝特类药物直接结合其配体结合域而被激活的。